Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma
Clinical trial NCT01393756 · COMPLETED
Trial details
- NCT number
- NCT01393756
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.